Presentation highlights include 48-month data from the OAKS and DERBY trials as well as the GALE open-label extension.

Ahmedabad: Three Class 10 students from Zebar School for Children have secured second place at the prestigious Ignite 2024-25 National Innovation Chal.

Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that five abstracts were accepted for oral presentation at the American Society of Retina Specialists (ASRS) Annual Scientific Meeting to ...

It's not only caused by needing corrective lenses. Leading eye doctors share which conditions—big and small—can cause blurry ...

The trial will evaluate the safety and tolerability of Tinlarebant and its potential to reduce atrophic lesion growth rate in ...

After doctors dismissed a white dot in her newborn’s eye as a birthmark, Maggie Spicer’s instincts led to a diagnosis that ...

Dilated pupils in cats can be a sign of iris atrophy or a more serious underlying condition. Here’s how to know when to seek ...

PST-611-CT1 is a first-in-human single ascending dose study that aims to establish, in six to a maximum of 12 dry AMD/GA patients, the safety profile of the drug and validate the maximal tolerated ...

Recent evidence has raised questions regarding the value of the traditional high-dose corticosteroids and optic nerve decompression approaches used for traumatic optic neuropathy.